Apogem closes Secondary Fund VII with NYLife LP commitment

Apogem announced the final close of Secondary Fund VII targeting North American middle-market GP-led and LP secondary transactions. New York Life Insurance Company is named as a committing LP. No individual amount is disclosed; fund hard cap differs from employee-inclusive raised capital.